Bristol-Meyers Squibb Co. Stock Drops After Investigation Announcement

Article

NEW YORK-Federal investigators are looking at pharmaceutical giant Bristol-Meyers Squibb Co. after reports that the company gave free drugs and devices to doctors in exchange for purchase of other Bristol drugs.

Bristol stock fell 3% Tuesday after the announcement. A company spokesperson said it was cooperating with the federal investigation and felt its pricing practices complied with the law.

Investigators are also looking at whether the company encouraged doctors to bill Medicare and Medicaid improperly.

Information from www.usatoday.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)